Copyright © 2011 Olivier M. Vanakker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. R. L. Sacco, J. H. Ellenberg, J. P. Mohr et al., “Infarcts of undetermined cause: the NINCDS Stroke Data Bank,” Annals of Neurology, vol. 25, no. 4, pp. 382–390, 1989. View at Scopus
2. A. Orlacchio and G. Bernardi, “Research actuality in the genetics of stroke,” Clinical and Experimental Hypertension, vol. 28, no. 3-4, pp. 191–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
3. A. Hassan and H. S. Markus, “Genetics and ischaemic stroke,” Brain, vol. 123, no. 9, pp. 1784–1812, 2000. View at Scopus
4. L. Morgan and S. E. Humphries, “The genetics of stroke,” Current Opinion in Lipidology, vol. 16, no. 2, pp. 193–199, 2005. View at Scopus
5. J. Myllyharju and K. I. Kivirikko, “Collagens and collagen-related diseases,” Annals of Medicine, vol. 33, no. 1, pp. 7–21, 2001. View at Scopus
6. D. M. Milewicz, Z. Urbán, and C. Boyd, “Genetic disorders of the elastic fiber system,” Matrix Biology, vol. 19, no. 6, pp. 471–480, 2000. View at Publisher · View at Google Scholar · View at Scopus
7. M. Czarny-Ratajczak and A. Latos-Bieleńska, “Collagens, the basic proteins of the human body,” Journal of Applied Genetics, vol. 41, no. 4, pp. 317–330, 2000. View at Scopus
8. P. Beighton, A. De Paepe, B. Steinmann, P. Tsipouras, and R. J. Wenstrup, “Ehlers-danlos syndromes: revised nosology,” American Journal of Medical Genetics, vol. 77, no. 1, pp. 31–37, 1998. View at Scopus
9. P. Beighton, A. De Paepe, J. G. Hall et al., “Molecular nosology of heritable disorders of connective tissue,” American Journal of Medical Genetics, vol. 42, no. 4, pp. 431–448, 1992. View at Scopus
10. G. S. Oderich, J. M. Panneton, T. C. Bower et al., “The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience,” Journal of Vascular Surgery, vol. 42, no. 1, pp. 98–106, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
11. S. Savasta, P. Merli, M. Ruggieri, L. Bianchi, and M. V. Spartà, “Ehlers-Danlos syndrome and neurological features: a review,” Child's Nervous System. In press. View at Publisher · View at Google Scholar · View at PubMed
12. K. N. North, D. A. H. Whiteman, M. G. Pepin, and P. H. Byers, “Cerebrovascular complications in Ehlers-Danlos syndrome type IV,” Annals of Neurology, vol. 38, no. 6, pp. 960–964, 1995. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. W. I. Schievink, M. Limburg, J. W. E. Oorthuys, P. Fleury, and F. M. Pope, “Cerebrovascular disease in Ehlers-Danlos syndrome type IV,” Stroke, vol. 21, no. 4, pp. 626–632, 1990. View at Scopus
14. A. Edwards and G. W. Taylor, “Ehlers-Danlos syndrome with vertebral artery aneurysm,” Proceedings of the Royal Society of Medicine, vol. 62, no. 7, pp. 734–735, 1969. View at Scopus
15. F. H. Mirza, P. L. Smith, and W. N. Lim, “Multiple aneurysms in a patient with Ehlers-Danlos syndrome: angiography without sequelae,” American Journal of Roentgenology, vol. 132, no. 6, pp. 993–995, 1979. View at Scopus
16. M. Pepin, U. Schwarze, A. Superti-Furga, and P. H. Byers, “Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type,” New England Journal of Medicine, vol. 342, no. 10, pp. 673–680, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
17. M. K. RUBINSTEIN and N. H. COHEN, “Ehlers–Danlos syndrome associated with multiple intracranial aneurysms,” Neurology, vol. 14, pp. 125–132, 1964. View at Scopus
18. A. Schoolman and J. J. Kepes, “Bilateral spontaneous carotid-cavernous fistulae in Ehlers-Danlos syndrome. Case report,” Journal of Neurosurgery, vol. 26, no. 1, pp. 82–86, 1967. View at Scopus
19. P. Forlodou, A. De Kersaint-Gilly, J. Pizzanelli, M. P. Viarouge, and E. Auffray-Calvier, “Ehlers-Danlos syndrome with a spontaneous caroticocavernous fistula occluded by detachable balloon: case report and review of literature,” Neuroradiology, vol. 38, no. 6, pp. 595–597, 1996. View at Publisher · View at Google Scholar · View at Scopus
20. H. A. Desal, F. Toulgoat, S. Raoul et al., “Ehlers-Danlos syndrome type IV and recurrent carotid-cavernous fistula: review of the literature, endovascular approach, technique and difficulties,” Neuroradiology, vol. 47, no. 4, pp. 300–304, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. M. H. Less, V. D. Menashe, C. O. Sunderland, C. L. Morgan, and P. J. Dawson, “Ehlers-Danlos syndrome associated with multiple pulmonary artery stenoses and tortuous systemic arteries,” The Journal of Pediatrics, vol. 75, no. 6, pp. 1031–1036, 1969. View at Scopus
22. S. Sultan, M. Morasch, M. P. Colgan, P. Madhavan, D. Moore, and G. Shanik, “Operative and endovascular management of extracranial vertebral artery aneurysm in Ehlers-Danlos syndrome: a clinical dilemma—case report and literature review,” Vascular and Endovascular Surgery, vol. 36, no. 5, pp. 389–392, 2002. View at Scopus
23. S. G. Mattar, A. G. Kumar, and A. B. Lumsden, “Vascular complications in Ehlers-Danlos syndrome,” American Surgeon, vol. 60, no. 11, pp. 827–831, 1994. View at Scopus
24. B. G. Hudson, S. T. Reeders, and K. Tryggvason, “Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of goodpasture and alport syndromes and diffuse leiomyomatosis,” Journal of Biological Chemistry, vol. 268, no. 35, pp. 26033–26036, 1993. View at Scopus
25. D. B. Gould, F. C. Phalan, G. J. Breedveld et al., “Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly,” Science, vol. 308, no. 5725, pp. 1167–1171, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. K. Vahedi, P. Massin, J. P. Guichard et al., “Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy,” Neurology, vol. 60, no. 1, pp. 57–63, 2003. View at Scopus
27. D. B. Gould, F. C. Phalan, S. E. Van Mil et al., “Role of COL4A1 in small-vessel disease and hemorrhagic stroke,” New England Journal of Medicine, vol. 354, no. 14, pp. 1489–1496, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. S. Lanfranconi and H. S. Markus, “COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review,” Stroke, vol. 41, pp. e513–e518, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. S. Shah, Y. Kumar, B. McLean et al., “A dominantly inherited mutation in collagen IV A1 (COL4A1) causing childhood onset stroke without porencephaly,” European Journal of Paediatric Neurology, vol. 14, no. 2, pp. 182–187, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
30. K. Vahedi, N. Kubis, M. Boukobza et al., “COL4A1 mutation in a patient with sporadic, recurrent intracerebral hemorrhage,” Stroke, vol. 38, no. 5, pp. 1461–1464, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. K. Vahedi, P. Massin, J. P. Guichard et al., “Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy,” Neurology, vol. 60, no. 1, pp. 57–63, 2003. View at Scopus
32. E. Plaisier, O. Gribouval, S. Alamowitch et al., “COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps,” New England Journal of Medicine, vol. 357, no. 26, pp. 2687–2695, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. S. Alamowitch, E. Plaisier, P. Favrole et al., “Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome,” Neurology, vol. 73, no. 22, pp. 1873–1882, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
34. F. Rauch and F. H. Glorieux, “Osteogenesis imperfecta,” The Lancet, vol. 363, no. 9418, pp. 1377–1385, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. P. H. Byers and W. J. Cole, “Osteogenesis imperfecta,” in Connective Tissue and Its Heritable Disorders: Molecular, Genetic and Medical Aspects, P. Royce and B. Steinmann, Eds., pp. 385–430, Wiley-liss, New York, NY, USA, 1979.
36. D. O. Silence, “Osteogenesis imperfecta: clinical variability and clas-sification,” in Symposium on Heritable Disease of Connective Tissue, W. H. Akeson, P. Bornstein, and M. J. Glimcher, Eds., pp. 223–247, Mosby, St. Louis, Mo, USA, 1982.
37. A. Gajko-Galicka, “Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans,” Acta Biochimica Polonica, vol. 49, no. 2, pp. 433–441, 2002. View at Scopus
38. W. A. Cabral, W. Chang, A. M. Barnes et al., “Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta,” Nature Genetics, vol. 39, no. 3, pp. 359–365, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. R. Morello, T. K. Bertin, Y. Chen et al., “CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta,” Cell, vol. 127, no. 2, pp. 291–304, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. M. C. Willing, S. P. Deschenes, R. L. Slayton, and E. J. Roberts, “Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains,” American Journal of Human Genetics, vol. 59, no. 4, pp. 799–809, 1996. View at Scopus
41. S. Mundlos, D. Chan, YI. M. Weng, D. O. Sillence, W. G. Cole, and J. F. Bateman, “Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened α2(I) chains show differential incorporation into the bone and skin extracellular matrix,” Journal of Biological Chemistry, vol. 271, no. 35, pp. 21068–21074, 1996. View at Publisher · View at Google Scholar · View at Scopus
42. Z. Verkh, M. Russell, and C. A. Miller, “Osteogenesis imperfecta type II: microvascular changes in the CNS,” Clinical Neuropathology, vol. 14, no. 3, pp. 154–158, 1995. View at Scopus
43. S. Albayram, O. Kizilkic, H. Yilmaz, B. Tuysuz, N. Kocer, and C. Islak, “Abnormalities in the cerebral arterial system in osteogenesis imperfecta,” American Journal of Neuroradiology, vol. 24, no. 4, pp. 748–750, 2003. View at Scopus
44. W. I. Schievink, V. V. Michels, and D. G. Piepgras, “Neurovascular manifestations of heritable connective tissue disorders: a review,” Stroke, vol. 25, no. 4, pp. 889–903, 1994. View at Scopus
45. S. Rouvière, R. Michelini, P. Sarda, and M. Pagès, “Spontaneous carotid artery dissection in two siblings with osteogenesis imperfecta,” Cerebrovascular Diseases, vol. 17, no. 2-3, pp. 270–272, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
46. F. Rauch and F. H. Glorieux, “Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?” Annals of Medicine, vol. 37, no. 4, pp. 295–302, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
47. V. E. Torres, P. C. Harris, and Y. Pirson, “Autosomal dominant polycystic kidney disease,” The Lancet, vol. 369, no. 9569, pp. 1287–1301, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
48. A. U. I. Haque and A. Moatasim, “Adult polycystic kidney disease: a disorder of connective tissue?” International Journal of Clinical and Experimental Pathology, vol. 1, pp. 84–90, 2008.
49. N. Hateboer, M. A.V. Dijk, N. Bogdanova et al., “Comparison of phonotypes of polycystic kidney disease types 1 and 2,” The Lancet, vol. 353, no. 9147, pp. 103–107, 1999. View at Publisher · View at Google Scholar
50. C. Deltas, “Cystic diseases of the kidney molecular biology and genetics,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 4, pp. 569–582, 2010. View at Scopus
51. Y. Pirson, D. Chauveau, and V. Torres, “Management of cerebral aneurysms in autosomal dominant polycystic kidney disease,” Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 269–276, 2002. View at Scopus
52. M. M. Belz, G. M. Fick-Brosnahan, R. L. Hughes et al., “Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease,” Kidney International, vol. 63, no. 5, pp. 1824–1830, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. T. Inagawa, “Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980–1989 and 1990–1998,” Stroke, vol. 32, no. 7, pp. 1499–1507, 2001. View at Scopus
54. Y. Pei and T. Watnick, “Diagnosis and screening of autosomal dominant polycystic kidney disease,” Advances in Chronic Kidney Disease, vol. 17, no. 2, pp. 140–152, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
55. V. E. Torres, D. M. Wilson, R. R. Hattery, and J. W. Segura, “Renal stone disease in autosomal dominant polycystic kidney disease,” American Journal of Kidney Diseases, vol. 22, no. 4, pp. 513–519, 1993. View at Scopus
56. Y. Pirson, “Extrarenal manifestations of autosomal dominant polycystic kidney disease,” Advances in Chronic Kidney Disease, vol. 17, no. 2, pp. 173–180, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
57. G. F. Gibbs, J. Huston, QI. Qian et al., “Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease,” Kidney International, vol. 65, no. 5, pp. 1621–1627, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
58. K. Neldner and B. Struk, “Pseudoxanthoma elasticum,” in Connective Tissue and Its Heritable Disorders, pp. 561–583, Wiley-Liss, New York, NY, USA, 2002.
59. O. M. Vanakker, B. P. Leroy, P. Coucke et al., “Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart,” Human mutation, vol. 29, no. 1, p. 205, 2008. View at Scopus
60. O. Le Saux, Z. Urban, C. Tschuch et al., “Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum,” Nature Genetics, vol. 25, no. 2, pp. 223–227, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
61. O. M. Vanakker, L. Martin, L. J. Schurgers et al., “Low serum vitamin K in PXE results in defective carboxylation of mineralization inhibitors similar to the GGCX mutations in the PXE-like syndrome,” Laboratory Investigation, vol. 90, no. 6, pp. 895–905, 2010. View at Publisher · View at Google Scholar · View at PubMed
62. A. Bock and G. Schwegler, “Intracerebral haemorrhage as first manifestation of Pseudoxanthoma elasticum,” Clinical Neurology and Neurosurgery, vol. 110, no. 3, pp. 262–264, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
63. S. Van Soest, J. Swart, N. Tijmes, L. A. Sandkuijl, J. Rommers, and A. A. B. Bergen, “A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1,” Genome Research, vol. 7, no. 8, pp. 830–834, 1997. View at Scopus
64. J. J. Wegman, X. Hu, H. Tan et al., “Patients with premature coronary artery disease who carry the ABCC6 R1141X mutation have no Pseudoxanthoma Elasticum phenotype,” International Journal of Cardiology, vol. 100, no. 3, pp. 389–393, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. G. Köblös, H. Andrikovics, Z. Prohászka, A. Tordai, A. Váradi, and T. Arányi, “The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease,” Genetic Testing and Molecular Biomarkers, vol. 14, no. 1, pp. 75–78, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. O. M. Vanakker, L. Martin, D. Gheduzzi et al., “Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity,” Journal of Investigative Dermatology, vol. 127, no. 3, pp. 581–587, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
67. P. Bhatnagar, K. B. Freund, R. F. Spaide et al., “Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum,” Retina, vol. 27, no. 7, pp. 897–902, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
68. V. Cãadas, I. Vilacosta, I. Bruna, and V. Fuster, “Marfan syndrome. Part 1: pathophysiology and diagnosis,” Nature Reviews Cardiology, vol. 7, no. 5, pp. 256–265, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
69. P. N. Robinson, E. Arteaga-Solis, C. Baldock et al., “The molecular genetics of Marfan syndrome and related disorders,” Journal of Medical Genetics, vol. 43, no. 10, pp. 769–787, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
70. P. C. Spittell, J. A. Spittell, J. W. Joyce et al., “Clinical features and differential diagnosis of aortic dissection: experience with 236 cases (1980 through 1990),” Mayo Clinic Proceedings, vol. 68, no. 7, pp. 642–651, 1993. View at Scopus
71. M. G. Austin and R. F. Schaeffer, “Marfan's syndrome with unusual blood vessel manifestations,” American Medical Association, vol. 64, pp. 205–209, 1957.
72. R. J. Wityk, C. Zanferrari, and S. Oppenheimer, “Neurovascular complications of Marfan syndrome: a retrospective, hospital-based study,” Stroke, vol. 33, no. 3, pp. 680–684, 2002. View at Publisher · View at Google Scholar · View at Scopus
73. J. E. Conway, G. M. Hutchins, and R. J. Tamargo, “Marfan syndrome is not associated with intracranial aneurysms,” Stroke, vol. 30, no. 8, pp. 1632–1636, 1999. View at Scopus
74. W. I. Schievink, R. J. Tamargo, J. E. Conway, and G. M. Hutchins, “Marfan syndrome and intracranial aneurysms,” Stroke, vol. 30, no. 12, pp. 2767–2768, 1999. View at Scopus
75. B. L. Loeys, H. C. Dietz, A. C. Braverman et al., “The revised Ghent nosology for the Marfan syndrome,” Journal of Medical Genetics, vol. 47, no. 7, pp. 476–485, 2010. View at Publisher · View at Google Scholar · View at PubMed
76. J. C. S. Dean, “Marfan syndrome: clinical diagnosis and management,” European Journal of Human Genetics, vol. 15, no. 7, pp. 724–733, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
77. P. Matt, J. Habashi, T. Carrel, D. E. Cameron, J. E. Van Eyk, and H. C. Dietz, “Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?” Journal of Thoracic and Cardiovascular Surgery, vol. 135, no. 2, pp. 389–394, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
78. B. L. Loeys, J. Chen, E. R. Neptune et al., “A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2,” Nature Genetics, vol. 37, no. 3, pp. 275–281, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
79. B. L. Loeys, U. Schwarze, T. Holm et al., “Aneurysm syndromes caused by mutations in the TGF-β receptor,” New England Journal of Medicine, vol. 355, no. 8, pp. 788–798, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
80. M. D. Everitt, N. Pinto, J. A. Hawkins, M. B. Mitchell, P. C. Kouretas, and A. T. Yetman, “Cardiovascular surgery in children with Marfan syndrome or Loeys-Dietz syndrome,” Journal of Thoracic and Cardiovascular Surgery, vol. 137, no. 6, pp. 1327–1333, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
81. S. A. LeMaire, H. Pannu, V. Tran-Fadulu, S. A. Carter, J. S. Coselli, and D. M. Milewicz, “Severe aortic and arterial aneurysms associated with a TGFBR2 mutation,” Nature Clinical Practice Cardiovascular Medicine, vol. 4, no. 3, pp. 167–171, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
82. M. L. Williams, S. B. Wechsler, and G. C. Hughes, “Two-stage total aortic replacement for Loeys-dietz syndrome,” Journal of Cardiac Surgery, vol. 25, no. 2, pp. 223–224, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
83. C. Ward, “Clinical significance of the bicuspid aortic valve,” Heart, vol. 83, no. 1, pp. 81–85, 2000. View at Scopus
84. P. W. M. Fedak, S. Verma, T. E. David, R. L. Leask, R. D. Weisel, and J. Butany, “Clinical and pathophysiological implications of a bicuspid aortic valve,” Circulation, vol. 106, no. 8, pp. 900–904, 2002. View at Publisher · View at Google Scholar · View at Scopus
85. L. Cripe, G. Andelfinger, L. J. Martin, K. Shooner, and D. W. Benson, “Bicuspid aortic valve is heritable,” Journal of the American College of Cardiology, vol. 44, no. 1, pp. 138–143, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
86. V. Garg, A. N. Muth, J. F. Ransom et al., “Mutations in NOTCH1 cause aortic valve disease,” Nature, vol. 437, no. 7056, pp. 270–274, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
87. M. Wolf and C. T. Basson, “The molecular genetics of congenital heart disease: a review of recent developments,” Current Opinion in Cardiology, vol. 25, no. 3, pp. 192–197, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
88. W. I. Schievink and B. Mokri, “Familial aorto-cervicocephalic arterial dissections and congenitally bicuspid aortic valve,” Stroke, vol. 26, no. 10, pp. 1935–1940, 1995. View at Scopus
89. W. I. Schievink, B. Mokri, D. G. Piepgras, and A. C. Gittenberger-de Groot, “Intracranial aneurysms and cervicocephalic arterial dissections associated with congenital heart disease,” Neurosurgery, vol. 39, no. 4, pp. 685–689, 1996. View at Scopus
90. W. I. Schievink, “Intracranial aneurysms,” The New England Journal of Medicine, vol. 336, pp. 28–40, 1997.
91. W. I. Schievink, S. S. Raissi, M. M. Maya, and A. Velebir, “Screening for intracranial aneurysms in patients with bicuspid aortic valve,” Neurology, vol. 74, no. 18, pp. 1430–1433, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
92. S. C. Siu and C. K. Silversides, “Bicuspid aortic valve disease,” Journal of the American College of Cardiology, vol. 55, no. 25, pp. 2789–2800, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
93. P. Franceschini, A. Guala, D. Licata, G. Di Cara, and D. Franceschini, “Arterial tortuosity syndrome,” American Journal of Medical Genetics, vol. 91, no. 2, pp. 141–143, 2000. View at Publisher · View at Google Scholar · View at Scopus
94. B. L. Callewaert, A. Willaert, W. S. Kerstjens-Frederikse et al., “Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families,” Human Mutation, vol. 29, no. 1, pp. 150–158, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
95. P. J. Coucke, A. Willaert, M. W. Wessels et al., “Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome,” Nature Genetics, vol. 38, no. 4, pp. 452–457, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
96. B. A. Pletcher, J. E. Fox, R. A. Boxer et al., “Four sibs with arterial tortuosity: description and review of the literature,” American Journal of Medical Genetics, vol. 66, no. 2, pp. 121–128, 1996. View at Publisher · View at Google Scholar · View at Scopus
97. M. S. Cartwright, W. H. Hickling, and E. S. Roach, “Ischemic stroke in an adolescent with arterial tortuosity syndrome,” Neurology, vol. 67, no. 2, pp. 360–361, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
98. C. Stamm, I. Friehs, S. Y. Ho, A. M. Moran, R. A. Jonas, and P. J. Del Nido, “Congenital supravalvar aortic stenosis: a simple lesion?” European Journal of Cardio-thoracic Surgery, vol. 19, no. 2, pp. 195–202, 2001. View at Publisher · View at Google Scholar · View at Scopus
99. B. R. Pober, “Williams-Beuren syndrome,” New England Journal of Medicine, vol. 362, no. 3, pp. 239–252, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
100. C. A. Morris, “Genetic aspects of supravalvular aortic stenosis,” Current Opinion in Cardiology, vol. 13, no. 3, pp. 214–219, 1998. View at Scopus
101. D. Kitchiner, M. Jackson, K. Walsh, I. Peart, and R. Arnold, “Prognosis of supravalve aortic stenosis in 81 patients in Liverpool (1960–1993),” Heart, vol. 75, no. 4, pp. 396–402, 1996.
102. J. B. Wollack, M. Kaifer, M. P. Lamonte, and M. Rothman, “Stroke in Williams syndrome,” Stroke, vol. 27, no. 1, pp. 143–146, 1996. View at Scopus
103. T. Kalbhenn, L. M. Neumann, W. R. Lanksch, and H. Haberl, “Spontaneous intracerebral hemorrhage and multiple infarction in Williams-Beuren syndrome,” Pediatric Neurosurgery, vol. 39, no. 6, pp. 335–338, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
104. W. I. Schievink, “Spontaneous dissection of the carotid and vertebral arteries,” New England Journal of Medicine, vol. 344, no. 12, pp. 898–906, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
105. K. Mondon, B. De Toffol, G. Georgesco et al., “Dissections simultanées des deux artères carotides internes et des deux artères vertébrales révélatrices d'un Syndrome d'Ehlers-Danlos type IV,” Revue Neurologique, vol. 160, pp. 478–482, 2004.
106. S. Rouvière, R. Michelini, P. Sarda, and M. Pagès, “Spontaneous carotid artery dissection in two siblings with osteogenesis imperfecta,” Cerebrovascular Diseases, vol. 17, no. 2-3, pp. 270–272, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
107. S. A. Mayer, B. S. Rubin, B. J. Starman, and P. H. Byers, “Spontaneous multivessel cervical artery dissection in a patient with a substitution of alanine for glycine (G13A) in the α1(I) chain of type I collagen,” Neurology, vol. 47, no. 2, pp. 552–556, 1996. View at Scopus
108. I. Hausser, U. Müller, S. Engelter et al., “Different types of connective tissue alterations associated with cervical artery dissections,” Acta Neuropathologica, vol. 107, no. 6, pp. 509–514, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
109. F. Von Pein, M. Välkkilä, R. Schwarz et al., “Analysis of the COL3A1 gene in patients with spontaneous cervical artery dissections,” Journal of Neurology, vol. 249, no. 7, pp. 862–866, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
110. C. Grond-Ginsbach, R. Weber, J. Haas et al., “Mutations in the COL5A1 coding sequence are not common in patients with spontaneous cervical artery dissections,” Stroke, vol. 30, no. 9, pp. 1887–1890, 1999. View at Scopus
111. C. Grond-Ginsbach, F. Wigger, M. Morcher et al., “Sequence analysis of the COL5A2 gene in patients with spontaneous cervical artery dissections,” Neurology, vol. 58, no. 7, pp. 1103–1105, 2002. View at Scopus
112. M. Morcher, I. Hausser, T. Brandt, and C. Grond-Ginsbach, “Heterozygous carriers of Pseudoxanthoma elasticum were not found among patients with cervical artery dissections,” Journal of Neurology, vol. 250, no. 8, pp. 983–986, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
113. S. Debette, T. M. Metso, A. Pezzini et al., “CADISP-genetics: an International project searching for genetic risk factors of cervical artery dissections,” International Journal of Stroke, vol. 4, no. 3, pp. 224–230, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
114. W. I. Schievink, B. Mokri, D. G. Piepgras, and J. D. Kuiper, “Recurrent spontaneous arterial dissections: risk in familial versus nonfamilial disease,” Stroke, vol. 27, no. 4, pp. 622–624, 1996. View at Scopus
115. J. J. Martin, I. Hausser, P. Lyrer et al., “Familial cervical artery dissections: clinical, morphologic, and genetic studies,” Stroke, vol. 37, no. 12, pp. 2924–2929, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
116. T. Brandt and C. Grond-Ginsbach, “Spontaneous cervical artery dissection: from risk factors toward pathogenesis,” Stroke, vol. 33, no. 3, pp. 657–658, 2002.
117. A. E. Guttmacher, D. A. Marchuk, and R. I. White Jr., “Hereditary hemorrhagic telangiectasia,” New England Journal of Medicine, vol. 333, no. 14, pp. 918–924, 1995. View at Publisher · View at Google Scholar · View at PubMed
118. K. A. McAllister, K. M. Grogg, D. W. Johnson et al., “Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1,” Nature Genetics, vol. 8, no. 4, pp. 345–351, 1994. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
119. G. Lesca, H. Plauchu, F. Coulet et al., “Molecular Screening of ALK1/ACVRL1 and ENG Genes in Hereditary Hemorrhagic Telangiectasia in France,” Human Mutation, vol. 23, no. 4, pp. 289–299, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
120. M. E. M. Porteous, A. Curtis, O. Williams, D. Marchuk, S. S. Bhattacharya, and J. Burn, “Genetic heterogeneity in hereditary haemorrhagic telangiectasia,” Journal of Medical Genetics, vol. 31, no. 12, pp. 925–926, 1994. View at Scopus
121. T. G. W. Letteboer, J. J. Mager, R. J. Snijder et al., “Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia,” Journal of Medical Genetics, vol. 43, no. 4, pp. 371–377, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
122. M. J. McDonald, B. P. Brophy, and C. Kneebone, “Rendu-Osler-Weber syndrome: a current perspective on cerebral manifestations,” Journal of Clinical Neuroscience, vol. 5, no. 3, pp. 345–350, 1998. View at Scopus
123. N. K. Singh and R. Kolluri, “Paradoxical systemic embolization in hereditary hemorrhagic telangiectasia,” Circulation. Cardiovascular imaging, vol. 1, no. 2, pp. e11–e12, 2008. View at Publisher · View at Google Scholar · View at PubMed
124. P. Bose, J. L. Holter, and G. B. Selby, “Bevacizumab in hereditary hemorrhagic telangiectasia,” New England Journal of Medicine, vol. 360, no. 20, pp. 2143–2144, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
125. F. S. Govani and C. L. Shovlin, “Hereditary haemorrhagic telangiectasia: a clinical and scientific review,” European Journal of Human Genetics, vol. 17, no. 7, pp. 860–871, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
126. R. Zarrabeitia, V. Albiñana, M. Salcedo, B. Señaris-Gonzalez, J.-L. Fernandez-Forcelledo, and L.-M. Botella, “A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT),” Current Vascular Pharmacology, vol. 8, no. 4, pp. 473–481, 2010. View at Publisher · View at Google Scholar
127. P. F. Plouin, J. Perdu, A. La Batide-Alanore, P. Boutouyrie, A. P. Gimenez-Roqueplo, and X. Jeunemaitre, “Fibromuscular dysplasia,” Orphanet Journal of Rare Diseases, vol. 2, no. 1, article 28, 2007. View at Publisher · View at Google Scholar · View at PubMed
128. J. C. Stanley, “Renal artery fibrodysplasia,” in Renal Vascular Disease, A. C. Novick, J. Scable, and G. Hamilton, Eds., pp. 21–23, WB Saunders, London, UK, 1996.
129. K. L. Mettinger, “Fibromuscular dysplasia and the brain. II. Current concept of the disease,” Stroke, vol. 13, no. 1, pp. 53–58, 1982.
130. H. J. Cloft, D. F. Kallmes, M. H. Kallmes, J. H. Goldstein, M. E. Jensen, and J. E. Dion, “Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment,” Journal of Neurosurgery, vol. 88, no. 3, pp. 436–440, 1998. View at Scopus
131. K. R. Stahlfeld, J. R. Means, and P. Didomenico, “Carotid artery fibromuscular dysplasia,” American Journal of Surgery, vol. 193, no. 1, pp. 71–72, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
132. M. C. CONNETT and J. M. LANSCHE, “Fibromuscular hyperplasia of the internal carotid artery: report of a case,” Annals of surgery, vol. 162, pp. 59–62, 1965. View at Scopus
133. H. Van Damme, N. Sakalihasan, and R. Limet, “Fibromuscular dysplasia of the internal carotid artery. Personal experience with 13 cases and literature review,” Acta Chirurgica Belgica, no. 4, pp. 163–168, 1999. View at Scopus
134. L. Chiche, A. Bahnini, F. Koskas, and E. Kieffer, “Occlusive fibromuscular disease of arteries supplying the brain: results of surgical treatment,” Annals of Vascular Surgery, vol. 11, no. 5, pp. 496–504, 1997. View at Publisher · View at Google Scholar · View at Scopus
135. L. A. Dayes and N. Gardiner, “The neurological implications of fibromuscular dysplasia,” Mount Sinai Journal of Medicine, vol. 72, no. 6, pp. 418–420, 2005. View at Scopus
136. E. Touzé, C. Oppenheim, D. Trystram et al., “Fibromuscular dysplasia of cervical and intracranial arteries,” International Journal of Stroke, vol. 5, no. 4, pp. 296–305, 2010. View at Publisher · View at Google Scholar · View at PubMed
137. A. Flex, E. Gaetani, P. Papaleo et al., “Proinflammatory genetic profiles in subjects with history of ischemic stroke,” Stroke, vol. 35, no. 10, pp. 2270–2275, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
138. S. Ye, P. Eriksson, A. Hamsten, M. Kurkinen, S. E. Humphries, and A. M. Henney, “Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression,” Journal of Biological Chemistry, vol. 271, no. 22, pp. 13055–13060, 1996. View at Publisher · View at Google Scholar
139. Y. M. Ruigrok, G. J. E. Rinkel, and C. Wijmenga, “The versican gene and the risk of intracranial aneurysms,” Stroke, vol. 37, no. 9, pp. 2372–2374, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
140. Y. M. Ruigrok, G. J. E. Rinkel, C. Wijmenga et al., “Association analysis of genes involved in the maintenance of the integrity of the extracellular matrix with intracranial aneurysms in a Japanese cohort,” Cerebrovascular Diseases, vol. 28, no. 2, pp. 131–134, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
141. J. T. Powell, “Abdominal aortic aneurysm,” in An Introduction to Vascular Biology, A. Halliday, B. J. Hunt, L. Poston, and M. Schachter, Eds., pp. 166–172, Cambridge University Press, Cambridge, UK, 1998.
142. D. G. Peters, A. Kassam, P. L. ST. Jean, H. Yonas, and R. E. Ferrell, “Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm,” Stroke, vol. 30, no. 12, pp. 2612–2616, 1999. View at Scopus
143. B. Zhang, S. Dhillon, I. Geary et al., “Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage,” Stroke, vol. 32, no. 9, pp. 2198–2202, 2001. View at Scopus
144. G. J. del Zoppo, “The neurovascular unit, matrix proteases, and innate inflammation,” Annals of the New York Academy of Sciences, vol. 1207, pp. 46–49, 2010. View at Publisher · View at Google Scholar · View at PubMed